Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Appendix Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04505553
What this trial is testing

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

Who this might be right for
Appendix CarcinomaColon CarcinomaEsophageal Carcinoma+10 more
University of Washington 78
Not applicableStudy completedNCT03852693
What this trial is testing

Distant Metastases and Long-Term Survival After Complete Resection of Neuroendocrine Tumors of the Appendix

Who this might be right for
Neuroendocrine Tumors of the Appendix
Insel Gruppe AG, University Hospital Bern 278
Not applicableStudy completedNCT05083338
What this trial is testing

Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy

Who this might be right for
Appendix CarcinomaCarcinomatosisColorectal Carcinoma+3 more
M.D. Anderson Cancer Center 24
Not applicableActive Not RecruitingNCT01946854
What this trial is testing

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

Who this might be right for
Gastrointestinal Neoplasms
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)Looking for participantsNCT05472948
What this trial is testing

Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma

Who this might be right for
Adenocarcinoma of Small IntestineAppendix CarcinomaMetastatic
Sun Yat-sen University 36
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableUnknownNCT05919758
What this trial is testing

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

Who this might be right for
NeoplasmsAppendix Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 1,000
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT05734430
What this trial is testing

Genetics of Appendix Cancer Study

Who this might be right for
Appendix CancerAppendiceal CancerAppendiceal Neoplasms+12 more
Andreana Holowatyj, PhD, MSCI 700
Testing effectiveness (Phase 2)Study completedNCT05185947
What this trial is testing

Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis

Who this might be right for
Gynecologic CancerGynecologic NeoplasmsPeritoneal Carcinomatosis+9 more
National Cancer Institute (NCI) 21
Early research (Phase 1)WithdrawnNCT06216561
What this trial is testing

Intraperitoneal LSTA1 in CRS-HIPEC

Who this might be right for
Colorectal CancerOvarian CarcinomaAppendix Cancer+1 more
University of California, San Diego
Not applicableStudy completedNCT05452382
What this trial is testing

Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma

Who this might be right for
Appendiceal Cancer
Mansoura University 2,607
Not applicableStudy completedNCT01126346
What this trial is testing

Quality of Life and Survivorship Care in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Advanced Malignant MesotheliomaCarcinoma of the AppendixOvarian Sarcoma+13 more
Wake Forest University Health Sciences 10
Early research (Phase 1)Study completedNCT00003548
What this trial is testing

Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity

Who this might be right for
Cancer
NYU Langone Health 20
Large-scale testing (Phase 3)Looking for participantsNCT06513065
What this trial is testing

Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Who this might be right for
Pseudomyxoma Peritonei
University of Southampton 176
Testing effectiveness (Phase 2)Active Not RecruitingNCT05194995
What this trial is testing

JAB-21822 in Combination With Cetuximab in Patients With Advanced CRC and Other Solid Tumors With KRAS G12C Mutation

Who this might be right for
Advanced Colorectal CancerSmall Intestinal CancerAppendiceal Cancer
Allist Pharmaceuticals, Inc. 48
Testing effectiveness (Phase 2)Study completedNCT02963831
What this trial is testing

Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies

Who this might be right for
Colorectal CancerOvarian CancerAppendiceal Cancer
Ludwig Institute for Cancer Research 67
Next Page